Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-058-1 | CAS number: 77-78-1
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
- Additional information:
According to the EU risk assessment report (2002) the following is noted in view of the two availabel skin sensitisation studies:
"Sensitising activity of DMS was tested in a murine local lymph node assay. Topical dosing of DMS (0.25, 0.5, and 1.0% in acetone/olive oil 80/20 v/v, number of animals not indicated) increased thymidine isotope incorporation in the lymph nodes more than 3-fold compared with vehicle-treated controls. A threefold increase was considered to be determinant of sensitising capacity (Ashby et al., 1995). It is noted that the positive response with DMS may be due to the corrosive properties. The Ear-Flank Test, however, showed an irregular reaction in a group of six guinea pigs treated with 10% DMS in olive oil. Interpretation of this result by the author was that DMS is a compound that does not cause sensitisation (Stevens, 1967). However this test is considered not suitable for evaluation, because the time between induction and challenge is considered to be too short."
However, due to the fact that a human case study with additional patch testing was made available by Yagami et al in 2009 (see 7.10.4) which havs been shown that DMS causes allergic contact dermatitis the classification of DMS as skin sensitiser.
Respiratory sensitisation
Endpoint conclusion
- Additional information:
According to the EU risk assessment report, 2002:
There are neither data from human experience nor other indications for respiratory sensitisation. Therefore at present there is no need to request further information.
Justification for classification or non-classification
According to regulation (EC) 1272/2008 DMS has to be classified as "skin sens. 1" H317: May cause an allergic contact dermatitis.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
